Opposition To Kenyan “Anti-Innovation” ICT Bill Grows 13/07/2016 by Maina Waruru for Intellectual Property Watch 1 Comment A bill introduced in Kenya’s parliament intended to streamline, govern and regulate the country’s information and communications technology (ICT) sector has been met with opposition from different quarters over fears that it could put ICT technicians out of practice and stifle the country’s innovation capacity if passed into law.
US Industry Airs Hopes, Frustrations On IP Rights In India 05/07/2016 by Patralekha Chatterjee for Intellectual Property Watch Leave a Comment What do global innovators make of India’s new National Intellectual Property Rights Policy? A recent discussion on “India’s National IPR Strategy: A View from Global Innovators” in Washington DC attempted to assess the opportunities and challenges ahead from the perspective of American companies.
Embassy In London Under Siege, IP A ‘Neo-Liberal Pillar’, Ecuador Minister Says 29/06/2016 by Catherine Saez, Intellectual Property Watch 1 Comment A top Ecuadoran official said today at the United Nations in Geneva that WikiLeaks founder Julian Assange’s health is deteriorating after four years confined in the Ecuadoran embassy in London, while the United Kingdom and Sweden are ignoring the findings of the UN Working Group on Arbitrary Detention which called for Assange’s release. The Ecuadoran Minister of Foreign Affairs also said Ecuador will carry on issuing compulsory licences for medicines as it sees fit, underlining the increasing role of intellectual property and the greater privatisation of knowledge.
South Centre Steps Up Activity On IP, Medicines Access, Trade, Investment And More 23/06/2016 by William New, Intellectual Property Watch 1 Comment The intergovernmental South Centre has raised the level of its activity on issues of relevance to the intellectual property community in recent weeks.
UN Development Agency Issues Guidelines For Pharmaceutical Patent Examiners 15/06/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment A new set of guidelines for pharmaceutical patent examination has been published by the United Nations Development Programme that seek to help reduce poor quality patents and ensure efficient market entry of generic products. The guidelines, written by a well-known advocate of access to medicines, aim at advising patent examiners in assessing the patentability requirements of applications relating to pharmaceutical products and processes.
Amid Allegations Of IP Theft By Corporations, Local Kenyan Innovators React 10/06/2016 by Fredrick Nzwili for Intellectual Property Watch 3 Comments NAIROBI, Kenya – As start-up and innovation centres spring up across Africa, Kenya – which birthed the continent’s tech movement – is emerging as one of its leading innovation nuclei. But concerns are intensifying here that young inventors are losing their innovations to conglomerates, in what is alleged as intellectual property theft or abuse.
Kenya’s Fledgling Innovation Agency Could Be Dissolved 10/06/2016 by Maina Waruru for Intellectual Property Watch 1 Comment NAIROBI, Kenya — Kenya could disband its infant innovation agency and have its functions taken up by the state’s science, technology and innovation body, if changes suggested by the government to reform the science, technology and innovation (ST&I) sector are carried through.
Rwanda Releases New Tariff Levels On IP, Signs UPOV 91 Biotech Rules 06/06/2016 by Hillary Muheebwa for Intellectual Property Watch Leave a Comment The government of Rwanda has revised the fees and cost to be paid for the registration of different categories of intellectual property rights. The changes mean lower fees for all types of IP rights, and gives more time to oppose registrations. Rwanda also enacted a law on seeds and plant varieties.
WHO Drafting Group Agrees Resolution On Health R&D 28/05/2016 by William New, Intellectual Property Watch 1 Comment A closed-door drafting group this evening arrived seemingly easily at agreement on a resolution on broadening work on new ways to fund research and development into medical products, according to participants. The agreement includes the creation of a new expert committee on health R&D, and asks for a WHO proposal on a pooled fund, they said. [Update: draft text now available]
WHO Reforms Health Emergency Response But Who Will Pay The Bill? 27/05/2016 by Mara Pillinger for Intellectual Property Watch Leave a Comment Two years after Ebola, the World Health Organization continues to push forward with a thorough overhaul of how it responds to health emergencies. These include Public Health Emergencies of International Concern (PHEICs), such as the Ebola and Zika outbreaks, as well as natural diseases, conflicts, refugee crises, and the like.